Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Sienna Cancer Diagnostics.
RELATED STOCKHEAD STORIES
Health & Biotech
Check up: Pot, takeovers, and COVID-19 are making investors happy
News
Lunchtime ASX Small Cap Wrap: Who wants to hear the good news today?
Health & Biotech
Bard1 makes Sienna an offer it can’t refuse: a $45m merger
News
10 at 10: These 10 ASX stocks are primed for Easter this morning
Health & Biotech
Health Kick Podcast: Learning from the Swine flu pandemic, the market potential of exosome therapeutics and jumping ASX life-sciences hurdles
News
Trading Places: The substantial holders that were buying and selling this week
Health & Biotech
Cancer Wars Part 2: These are the ASX small cap diagnostics plays that want to conquer cancer
News
Lunchtime ASX small cap wrap: Who’s started an intergenerational war today?
Health & Biotech
Health: Smiles bites down as it reveals an investigation into the ex-CEO’s behaviour
Health & Biotech
Sienna is selling its pee testers in South Korea to sniff out bladder cancer
Health & Biotech
Fliers, flameouts and fakers: what happened in biotechland in 2018
IPO Watch
IPO Watch: who’s going ahead, who’s on hold and who’s missing in action
Health & Biotech
Sienna looks to $7bn cancer diagnostics market
Health & Biotech
